{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T20:09:17Z","timestamp":1648843757275},"reference-count":20,"publisher":"Baishideng Publishing Group Inc.","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJCC"],"published-print":{"date-parts":[[2020,11,6]]},"DOI":"10.12998\/wjcc.v8.i21.5172","type":"journal-article","created":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T03:58:04Z","timestamp":1604635084000},"page":"5172-5179","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and safety of S-1 maintenance therapy in advanced non-small-cell lung cancer patients"],"prefix":"10.12998","volume":"8","author":[{"given":"Xiao-Wei","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Hua","family":"Leng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Ling","family":"Mu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2060","reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv187"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.4972"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000013464"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.7150\/jca.21151"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyz064"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s00066-017-1113-1"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1080\/14737140.2019.1699407"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2017.06.05"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000006165"},{"key":"B10","unstructured":"Murakami S, Saito H, Kondo T, Oshita F, Yamada K. Phase II study of bevacizumab, cisplatin, and pemetrexed in advanced non-squamous non-small cell lung cancer (NS-NSCLC) with EGFR wild-type. J Exp Ther Oncol 2019; 13: 131-138"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S219722"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.21147\/j.issn.1000-9604.2019.05.05"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.21873\/invivo.11704"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.01494"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-08399-8"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0149247"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.13056"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-017-0537-6"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1080\/19336918.2019.1638690"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1080\/1354750X.2019.1583771"}],"container-title":["World Journal of Clinical Cases"],"original-title":[],"link":[{"URL":"https:\/\/www.wjgnet.com\/2307-8960\/full\/v8\/i21\/5172.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T03:58:36Z","timestamp":1604635116000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.wjgnet.com\/2307-8960\/full\/v8\/i21\/5172.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,6]]},"references-count":20,"journal-issue":{"issue":"21"},"URL":"https:\/\/doi.org\/10.12998\/wjcc.v8.i21.5172","relation":{},"ISSN":["2307-8960"],"issn-type":[{"value":"2307-8960","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11,6]]}}}